Akt, MAPK (Erk1/2), and p38 Act in Concert to Promote Apoptosis in Response to ErbB Receptor Family Inhibition
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (18) , 14842-14847
- https://doi.org/10.1074/jbc.m008786200
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Anticancer efficacy of the irreversible EGFr tyrosine kinase inhibitor PD 0169414 against human tumor xenograftsCancer Chemotherapy and Pharmacology, 2000
- Phosphorylation and Regulation of Raf by Akt (Protein Kinase B)Science, 1999
- Differentiation Stage-Specific Inhibition of the Raf-MEK-ERK Pathway by AktScience, 1999
- Heregulin Regulation of Akt/Protein Kinase B in Breast Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent ApoptosisPublished by Elsevier ,1999
- Inhibition of the Epidermal Growth Factor Receptor Family of Tyrosine Kinases as an Approach to Cancer Chemotherapy: Progression from Reversible to Irreversible InhibitorsPharmacology & Therapeutics, 1999
- Epidermal Growth Factor Protects Epithelial Cells against Fas-induced ApoptosisJournal of Biological Chemistry, 1999
- Role of an Anti-epidermal Growth Factor Receptor in Treating CancerCancer and Metastasis Reviews, 1999
- The Activation of p38 and Apoptosis by the Inhibition of Erk Is Antagonized by the Phosphoinositide 3-Kinase/Akt PathwayJournal of Biological Chemistry, 1998
- Correlation between Sustained c-Jun N-terminal Protein Kinase Activation and Apoptosis Induced by Tumor Necrosis Factor-α in Rat Mesangial CellsJournal of Biological Chemistry, 1998